Gandhi Hardik, Maru Alpeshkumar, Shah Niyati, Mansuriya Ravi Kumar, Rathod Gunvanti, Parmar Pragnesh
Department of Pathology, KMCRI, Bharuch,Gujarat, India.
Department of Pathology, Dr N D Desai Faculty of Medical Science & Research, Nadiad, Gujarat, India.
Maedica (Bucur). 2023 Mar;18(1):55-60. doi: 10.26574/maedica.2023.18.1.55.
Invasive carcinoma of the breast is one of the leading causes of death in women. In developing countries, fine needle aspiration cytology (FNAC) of the breast is used for preoperative diagnosis of breast cancer due to low cost. The grading system of breast carcinoma on FNAC is widely accepted. In the era of neoadjuvant therapy, if grading of breast carcinoma is incorporated in FNAC reports for prognostication, it will be of great help especially in patients with locally advanced disease, older patients with accompanying chronic disease and patients who reject surgery. Hence, there is much to be gained by grading a tumor on FNAC. The present study was conducted on 40 cases of cytologically diagnosed breast carcinomas. Fine needle aspiration cytology smears were graded by Robinson cytological grading system. All surgical specimens were processed and the histological grading of the resulting slides was done by the Nottingham modification of Bloom Richardson score. Then, the cytological grade was compared with the histological grade and statistical analysis was done. Based on Robinson grading method, cases were classified into grade I (15%), grade II (55%) and grade III (30%). Based on the Nottingham modification of Bloom Richardson (SBR) grading method, the cases were classified as grade I (5%) and grade II and III (47.5%) each. A total concordance rate between both the grading systems was seen in 65% of cases. A positive correlation was found and there was a significant association between Robinson cytological grading and SBR histological grading. Grading breast carcinoma on cytology allows its prognostic evaluation along with diagnostic value without any additional morbidity or expense to the patient. Thus, it is recommended to grade breast carcinomas on FNAC. It helps in deciding the proper line of treatment, so that patients can have a better prognosis.
乳腺浸润性癌是女性主要死因之一。在发展中国家,由于成本低廉,乳腺细针穿刺细胞学检查(FNAC)被用于乳腺癌的术前诊断。乳腺FNAC的分级系统已被广泛接受。在新辅助治疗时代,如果将乳腺癌分级纳入FNAC报告以进行预后评估,将大有帮助,尤其是对于局部晚期疾病患者、患有慢性病的老年患者以及拒绝手术的患者。因此,对FNAC上的肿瘤进行分级有很大益处。本研究对40例经细胞学诊断的乳腺癌病例进行。细针穿刺细胞学涂片采用罗宾逊细胞学分级系统进行分级。所有手术标本均进行处理,所得切片的组织学分级采用布卢姆 - 理查森评分的诺丁汉改良法进行。然后,将细胞学分级与组织学分级进行比较并进行统计分析。根据罗宾逊分级方法,病例分为I级(15%)、II级(55%)和III级(30%)。根据布卢姆 - 理查森(SBR)分级方法的诺丁汉改良法,病例分为I级(5%),II级和III级各占(47.5%)。两种分级系统之间的总一致性率在65%的病例中可见。发现存在正相关,罗宾逊细胞学分级与SBR组织学分级之间存在显著关联。对乳腺癌进行细胞学分级可在具有诊断价值的同时进行预后评估,而不会给患者带来任何额外的发病率或费用。因此,建议对FNAC上的乳腺癌进行分级。这有助于确定合适的治疗方案,从而使患者有更好的预后。